Full Length Research Paper
References
Agrawal N, Dasaradhi PVN, Mohmmed A, Malhotra P, Bhatnagar RK, Sunil KM (2003). RNA Interference: Biology, Mechanism, and Applications. Microbiol. Mol. Biol. Rev. 67:657-685. |
|
Amer HM (2011). Baculovirus expression vector system: An efficient tool for the production of heterologous recombinant proteins. Afr. J. Biotechnol. 10(32):5927-5933. |
|
Boshra H, Lorenzo G, Busquets N, Brun A (2011). Rift Valley Fever: Recent Insights into Pathogenesis and Prevention. J. Virol. 85(13):6098-6105. |
|
Braunagel SC, Summers MD (2007). Molecular biology of the baculovirus occlusion-derived virus envelope. Curr. Drug Targets 8(10):1084-1095. |
|
Breiman RF, Njenga MK, Cleaveland S, Sharif SK, Mbabu M, King L (2008). Lessons from the 2006–2007 Rift Valley fever outbreak in East Africa: Implications for prevention of emerging infectious diseases. Future Virol. 3:411-417. |
|
Brummelkamp TR, Bernards R, Agami R (2002). A system for stable expression of short interfering RNAs in mammalian cells. Science 296(5567):550-553. |
|
Bucher E, Lohuis D, van Poppel PMJA, Geerts-Dimitriadou C, Goldbach R, Prins M (2006). Multiple virus resistance at a high frequency using a single transgene construct. J. Gen. Virol. 87:3697-3701. |
|
Carmona S, Ely A, Crowther C, Moolla N, Salazar FH, Marion PL (2006). Effective inhibition of HBV replication in vivo by anti-HBx short hairpin RNAs. Mol. Ther. 13(2):411-421. |
|
CDC-Centers for Disease Control and Prevention (2007). Rift Valley fever outbreak Kenya, November 2006-January 2007. MMWR. Morbidity and mortality weekly report 56:73-76. |
|
Chalfie M, Kain S (1998). Green fluorescent protein: properties, applications, and protocols. New York: Wiley-Liss. |
|
Chalfie M, Tu Y, Euskirchen G, Prasher DC (1994). Green fluorescent protein as a marker for gene expression. Science 263(5148):802-805. |
|
Chap TL (2003). Introductory to Bioinformatics. John Wiley and Sons Publishing Inc., Hoboken, New Jersey, pp. 209-313. |
|
Ciccarone VC, Polayes D, Luckow VA (1997). Generation of Recombinant Baculovirus DNA in E. coli Using Baculovirus Shuttle Vector. In Methods Molec. Med. Edited by U. Reischt. Humana Press Inc., Totowa, NJ. P 13. |
|
Collett MS, Purchio AF, Keegan K, Frazier S, Hays W, Anderson DK (1985). Complete nucleotide sequence of the M RNA segment of Rift Valley fever virus. J. Virol. 144:228-245. |
|
Collins TJ (2007). ImageJ for microscopy. BioTechniques 43(1):25-30. |
|
Daubney R, Hudson JR, Garnham PC (1931). Enzootic hepatitis or Rift Valley fever. An undescribed virus disease of sheep, cattle and man from East Africa. J. Pathol. Bacteriol. 34:545-579. |
|
Easterday BC, McGavran MH, Rooney JR, Murphy LC (1962). The pathogenesis of Rift Valley fever in lambs. Am. J. Vet. Res. 23:470-479. |
|
Elliott RM (1990). Molecular biology of the Bunyaviridae. J. Gen. Virol. 71:501-522. |
|
Ellis DS, Shirodaria PV, Fleming E, Simpson DI (1988). Morphology and development of Rift Valley fever virus in Vero cell cultures. J. Med. Virol. 24(2):161-174. |
|
Faburay B, Wilson WC, Gaudreault NN, Davis AS, Shivanna V, Bawa B, Sunwoo SY, Ma W, Drolet BS, Morozov I, McVey DS (2016). A Recombinant Rift Valley Fever Virus Glycoprotein Subunit Vaccine Confers Full Protection against Rift Valley Fever Challenge in Sheep. Sci. Rep. 6:27719. |
|
Fisher LD, Belle GV (2004). Biostatistics: A methodology for the health sciences. Heagerty P. J and Lumley T. 2nd edition. John Wiley and Sons Inc., Hoboken, New Jersey, pp. 123-133. |
|
Fitzgerald K, White S, Borodovsky A, Bettencourt BR, Strahs A, Clausen V, Wijngaard P, Horton JD, Taubel J, Brooks A, Fernando C (2017). A Highly Durable RNAi Therapeutic Inhibitor of PCSK9. New Engl. J. Med. 376:41-51. |
|
Ge Q, Eisen HN, Chen J (2004). Use of siRNAs to prevent and treat influenza virus infection. J. Virus Res. 102(1):37-42. |
|
Giorgi C, Accardi L, Nicoletti L, Gro MC, Takehara K, Hilditch C, Morikawa S, Bishop DH (1991). Sequences and coding strategies of the S RNAs of Toscana and Rift Valley fever viruses compared to those of Punta Toro, Sicilian Sandfly fever, and Uukuniemi viruses. J. Virol. 180:738-753. |
|
Giorgi C (1996). Molecular biology of phlebovirus. In. The Bunyaviridae, Edited by R. M. Elliott. New York: Plenum Press. Pp. 105-128. |
|
Hannon GJ (2002). RNA interference. Nature 418:244-251. |
|
Hannon GJ, Rossi JJ (2004). Insightful review articles: Unlocking the potential of the human genome with RNA interference. Nature 431:371-378. |
|
Harris R, Polayes D (1997). A New Baculovirus Expression Vector for the Simultaneous Expression of Two Heterologous Proteins in the Same Insect Cell. Focus 19:6-8. |
|
Ikegami T, Makino S (2009). Rift Valley fever vaccines. Vaccine 27(S4):D69-D72. |
|
Jung J, Nayak A, Schaeffer V, Starzetz T, Kirsch AK, Müller S, Dikic I, Mittelbronn M, Behrends C (2017). Multiplex image-based autophagy RNAi screening identifies SMCR8 as ULK1 kinase activity and gene expression regulator. eLife 6:e23063. |
|
Kang S, Hong YS (2008). RNA Interference in Infectious Tropical Diseases. Korean J. Parasitol. 46(1):1-15. |
|
Kaps M, Lamberson WR (2004). Biostatistics for Animal Science. CAB international publishing, UK, pp. 53-153. |
|
Koch A, Biedenkopf D, Furch A, Weber L, Rossbach O, Abdellatef E, Linicus L, Johannsmeier J, Jelonek L, Goesmann A, Cardoza V (2016). An RNAi- Based Control of Fusarium graminearum Infections Through Spraying of Long dsRNAs Involves a Plant Passage and Is Controlled by the Fungal Silencing Machinery. PLoS Pathog. 12(10):e1005901. |
|
Li S, Patel DJ (2016). Drosha and Dicer: Slicers cut from the same cloth. Cell Res. 26:511-512. |
|
Linthicum KJ, Anyamba A, Tucker CJ, Kelley PW, Myers MF, Peters CJ (1999). Climate and satellite indicators to forecast Rift Valley fever epidemics in Kenya. Science 285:397-400. |
|
Liu DY, Tesh RB, Travassos D, Rosa AP, Peters CJ, Yang Z, Guzman H, Xiao SY (2003). Phylogenetic relationships among members of the genus Phlebovirus (Bunyaviridae) based on partial M segment sequence analyses. J. Gen. Virol. 84:465-473. |
|
McCaffrey AP, Meuse L, Pham TT, Conklin DS, Hannon GJ, Kay MA (2002). Gene expression: RNA interference in adult mice. Nature 418:338-339. |
|
McGinnis KM (2010). RNAi for functional genomics in plants. Brief. Funct. Genomics 9(2):111-117. |
|
Meegan JM, Hoogstraal H, Moussa MI (1979). An epizootic of Rift Valley fever in Egypt in 1977. J. Vet. Res. 105:124-125. |
|
Meegan JM, Watten RH, Laughlin LW (1981). Clinical experience with Rift Valley fever in humans during the 1977 Egyptian epizootic. Contribution on Epi Biostat 3:114-123. |
|
Meng Z, Zhang X, Wu J, Pei R, Xu Y, Yang D, Roggendorf M, Lu M (2013). RNAi Induces Innate Immunity through Multiple Cellular Signaling Pathways. PLoS One 8(5):e64708. |
|
Muller R, Poch O, Delarue M, Bishop DHL, Bouloy M (1994). Rift Valley fever virus L segment: correction of the sequence and possible functional role of newly identified regions conserved in RNA-dependent polymerases. J. Gen. Virol. 75(6):1345-1352. |
|
Nderitu L, Lee JS, Omolo J, Omulo S, O'Guinn ML, Hightower A, Mosha F, Mohamed M, Munyua P, Nganga Z, Hiett K, Seal B, Feikin DR, Breiman RF, Kariuki MN (2011). Sequential Rift Valley Fever Outbreaks in Eastern Africa Caused by Multiple Lineages of the Virus. J. Infect. Dis. 203(5):655-665. |
|
Nichol ST, Beaty BJ, Elliott RM, Goldbach RW, Plyusnin A, Tesh RB (2005). Classification and nomenclature of viruses. VIIIth report of the International Committee on Taxonomy of Viruses. In. The Bunyaviridae, Virus taxonomy. Edited by C. Fauquet, M.A. Mayo, L.S.M. Maniloff, U. Desselberger & L.A. Ball. Elsevier Academic Press, London. pp. 695-716. |
|
Nishitsuji H, Kohara M, Kannagi M, Masuda T (2006). Effective suppression of human immunodeficiency virus type 1 through a combination of short- or long-hairpin RNAs targeting essential sequences for retroviral integration. J. Virol. 80(15):7658-7666. |
|
O'Reilly DR, Miller LK, Luckow VA (1992). Baculovirus Expression Vectors: A Laboratory Manual, W. H. Freeman and Company, New York. |
|
Pepin M, Bouloy M, Bird BH, Kemp A, Paweska J (2010). Rift Valley fever virus (Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention. J. Vet. Res. 41(6):61. |
|
Pompey JM, Morf L, Singh U (2014). RNAi Pathway Genes Are Resistant to Small RNA Mediated Gene Silencing in the Protozoan Parasite Entamoeba histolytica. PLoS One 9(9):e106477. |
|
Sang R, Arum S, Chepkorir E, Mosomtai G, Tigoi C, Sigei F, Lwande OW, Landmann T, Affognon H, Ahlm C, Evander M (2017). Distribution and abundance of key vectors of Rift Valley fever and other arboviruses in two ecologically distinct counties in Kenya. PLoS Negl. Trop. Dis. 11(2):e0005341. |
|
Shi JY, Liu B, Wang M, Luo EJ (2010). Short hairpin RNA-mediated inhibition of measles virus replication in vitro. Can. J. Microbiol. 56:77-80. |
|
Sindato C, Pfeiffer DU, Karimuribo ED, Mboera LEG, Rweyemamu MM, Paweska JT (2015). A Spatial Analysis of Rift Valley Fever Virus Seropositivity in Domestic Ruminants in Tanzania. PLoS One 10(7):e0131873. |
|
Swamy MN, Wu H, Shankar P (2016). Recent advances in RNAi-based strategies for therapy and prevention of HIV-1/AIDS. Adv. Drug Deliv. Rev. 103:174-86. |
|
Swanepoel R, Coetzer JAW (2004). Rift Valley fever, In. Infectious diseases of livestock, Edited by J. A. W. Coetzer & R. C. Tustin. Oxford University Press, Cape Town, South Africa. Pp. 1037-1070. |
|
Tamura K, Dudley J, Nei M, Kumar S (2007). MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol. Biol. Evol. 24:1596-1599. |
|
Theilmann DA, Stewart S (1992). Molecular Analysis of the trans-Activating IE-2 Gene of Orgyia pseudotsugata Multicapsid Nuclear Polyhedrosis Virus. J. Virol. 187:84-96. |
|
Vlak JM, Keus RJA (1990). Baculovirus Expression Vector System for Production of Viral Vaccines. In. Viral Vaccines, Wiley-Liss Inc. pp. 91-128. |
|
WHO-World Health Organization (2007). Rift Valley Fever outbreak-Kenya, November 2006-January 2007. MMWR. Morbidity and Mortality Weekly Report 56:73-76. |
|
Yang S, Miller LK (1999). Activation of Baculovirus Very Late Promoters by Interaction with Very Late Factor 1. J. Virol. 73(4):3404-3409. |
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0